| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 418,5 k € | +2.4% | 408,6 k € | +11.0% | 367,9 k € | +13.3% | 324,7 k € | +38.4% | 234,5 k € | -13.7% | 271,7 k € | -6.8% | 291,5 k € | +14.6% | 254,5 k € | -9.7% | 281,7 k € | -5.6% | 298,4 k € | +25.3% | 238,1 k € | -0.1% | 238,4 k € | +9.3% | 218,0 k € | +0.6% | 216,7 k € | -7.3% | 233,7 k € | +75.2% | 133,4 k € | -12.5% | 152,4 k € | -6.7% | 163,4 k € | +15.9% | 140,9 k € | |
| EBITDA | 194,5 k € | -11.4% | 219,5 k € | +18.4% | 185,4 k € | +9.7% | 169,0 k € | +49.2% | 113,3 k € | -20.2% | 142,0 k € | -13.2% | 163,6 k € | -1.8% | 166,6 k € | -2.0% | 169,9 k € | -24.0% | 223,6 k € | +27.2% | 175,7 k € | -0.9% | 177,3 k € | +10.8% | 160,0 k € | +8.1% | 148,0 k € | +18.8% | 124,6 k € | +328.7% | 29,1 k € | -31.3% | 42,3 k € | -32.0% | 62,3 k € | -0.9% | 62,8 k € | |
| Operating profit | 117,7 k € | -17.6% | 142,9 k € | +68.1% | 85,0 k € | +38.5% | 61,4 k € | +225.2% | 18,9 k € | -58.8% | 45,8 k € | -35.2% | 70,7 k € | +6.9% | 66,2 k € | -0.1% | 66,2 k € | -46.0% | 122,6 k € | +29.6% | 94,6 k € | +54.8% | 61,1 k € | -52.5% | 128,7 k € | -4.1% | 134,1 k € | +20.2% | 111,6 k € | +621.6% | 15,5 k € | -46.1% | 28,7 k € | -42.4% | 49,8 k € | -12.3% | 56,8 k € | |
| Profit/loss | 81,6 k € | -19.7% | 101,7 k € | +80.5% | 56,4 k € | +25.4% | 44,9 k € | +54.2% | 29,1 k € | -38.0% | 47,0 k € | -26.9% | 64,4 k € | +57.0% | 41,0 k € | +1.3% | 40,5 k € | -55.7% | 91,4 k € | +25.9% | 72,6 k € | +40.9% | 51,5 k € | -46.1% | 95,6 k € | -14.3% | 111,6 k € | +15.7% | 96,5 k € | +143.3% | 39,6 k € | +52.8% | 25,9 k € | -34.3% | 39,5 k € | -12.2% | 45,0 k € | |
| Equity | 964,6 k € | +9.2% | 883,0 k € | +5.1% | 840,2 k € | +1.9% | 824,9 k € | -0.8% | 831,5 k € | +3.6% | 802,3 k € | +5.7% | 758,8 k € | +8.6% | 698,8 k € | +6.2% | 657,8 k € | -1.1% | 665,4 k € | +15.9% | 574,0 k € | +14.5% | 501,4 k € | +11.5% | 449,9 k € | -5.1% | 474,2 k € | +30.8% | 362,6 k € | +36.2% | 266,1 k € | -31.1% | 386,5 k € | +6.4% | 363,1 k € | +11.3% | 326,2 k € | |
| Total assets | 1,5 M € | -3.4% | 1,6 M € | +2.1% | 1,5 M € | -7.6% | 1,7 M € | +9.8% | 1,5 M € | -4.7% | 1,6 M € | -2.6% | 1,6 M € | -1.7% | 1,7 M € | -1.0% | 1,7 M € | -7.4% | 1,8 M € | +15.5% | 1,6 M € | -3.9% | 1,6 M € | -1.4% | 1,7 M € | +148.0% | 669,0 k € | +10.7% | 604,2 k € | +8.2% | 558,3 k € | +2.9% | 542,6 k € | +11.2% | 487,9 k € | +1.4% | 480,9 k € | |
| Cash | 336,7 k € | -23.0% | 437,3 k € | +10.3% | 396,4 k € | -2.9% | 408,3 k € | +4.3% | 391,4 k € | -1.3% | 396,7 k € | +6.8% | 371,5 k € | +29.0% | 288,1 k € | +36.7% | 210,7 k € | -40.4% | 353,4 k € | +10.4% | 320,3 k € | +3.7% | 308,9 k € | -68.1% | 967,1 k € | +214.5% | 307,5 k € | +24.6% | 246,8 k € | +56.3% | 158,0 k € | +1.0% | 156,4 k € | -7.7% | 169,4 k € | -8.8% | 185,7 k € | |
| Debts | 549,2 k € | -19.9% | 685,2 k € | -1.5% | 695,7 k € | -17.0% | 837,9 k € | +22.8% | 682,4 k € | -13.2% | 786,5 k € | -9.7% | 871,4 k € | -9.2% | 959,3 k € | -5.8% | 1,0 M € | -10.7% | 1,1 M € | +15.2% | 990,4 k € | -12.2% | 1,1 M € | -6.3% | 1,2 M € | +542.5% | 187,2 k € | -21.5% | 238,3 k € | -18.4% | 292,1 k € | +87.1% | 156,1 k € | +26.4% | 123,5 k € | -19.3% | 153,1 k € | |
| Staff | 2,9 | 2,8 | 2,9 | 2,4 | 2 | 2 | 2 | 1,5 | 2 | 1,3 | 1 | 1 | 1 | 1,2 | 2,4 | 2,3 | 2,3 | 2,3 | 2,1 | |||||||||||||||||||
Private limited company · Oosterzele · incorporated on 27/12/1984 · 2,9 ETP
Private limited company profitable and well capitalised. Cash position declining (-23.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Apotheek De Wael is a Private limited company incorporated in 1984. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oosterzele. It employs on average 2,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette